TransCode Therapeutics, Inc. · NASDAQ:RNAZ
TransCode Therapeutics, Inc. shareholders
As of Sep 30, 2026, 12 institutions reported holding TransCode Therapeutics, Inc., 0.58% of its shares. Largest: Yorkville Advisors Global, LP, Citadel and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of TransCode Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | 75,786 | 0.44% | +56,147 | Nov 12, 2026 |
| Citadel | 10,207 | 0.06% | new | Nov 16, 2026 |
| Vanguard | 9,527 | 0.06% | no change | Nov 13, 2026 |
| UBS | 2,650 | 0.02% | −238 | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 1,746 | 0.01% | +1,069 | Nov 16, 2026 |
| Osaic Holdings, Inc. | 270 | <0.01% | new | Nov 12, 2026 |
| Robinhood Markets, Inc. | 102 | <0.01% | first report | Nov 18, 2026 |
| Wells Fargo | 55 | <0.01% | no change | Nov 16, 2026 |
| SBI Securities Co., Ltd. | 12 | <0.01% | no change | Oct 21, 2026 |
| Fidelity | 11 | <0.01% | −695 | Nov 10, 2026 |